evolcSign inStart free
Menu

Vaxcyte

Clinical-stage vaccine developer of pneumococcal conjugate vaccines for infants and older adults, with Strep A and Shigella programs

United Statesvaxcyte.comWebsite technologies

+ Add to sales board

Highlights

  • Hiring4 open roles
  • Remote-friendly4 of 4 open roles remote or hybrid

About Vaxcyte

Vaxcyte develops vaccines against bacterial infections, with a lead franchise of pneumococcal conjugate vaccines (PCVs): VAX-31, a 31-valent candidate, and VAX-24, a 24-valent candidate, studied for the prevention of invasive pneumococcal disease. Its approach uses a cell-free protein synthesis platform and advanced chemistry to produce complex vaccines. Early-stage programs target Group A Strep and Shigella.

The candidates are aimed at infants, young children and older adults, and at people with immune deficiencies or certain chronic conditions. VAX-31 is in a Phase 3 adult clinical program and a Phase 2 infant program, and VAX-24 is in a Phase 2 infant program. The company does not sell products on the market, and its stated focus is clinical development and manufacturing of these candidates.

Vaxcyte was founded in 2013 and is headquartered in San Carlos, California. Its co-founder and CEO is Grant Pickering. The company has announced an investment of up to $1 billion in expanding U.S. manufacturing, including new vaccine production in North Carolina. At the time of the profile it listed 40 open roles, mostly in analytical development, manufacturing, quality, commercial and IT functions, based in San Carlos and Visp, Switzerland, with some remote U.S. positions.

Product: VAX-31 (31-valent) and VAX-24 (24-valent) pneumococcal conjugate vaccine candidates, plus early-stage Group A Strep and Shigella programs.

Jobs at Vaxcyte (4)

Vaxcyte is hiring for 4 roles in manufacturing and operations, based in Visp.

Leadership

  • Grant Pickering · Chief Executive Officer, Director and Co-Founder
    Source: company website
  • Andrew Guggenhime · President and Chief Financial Officer
    Source: company website
  • Jim Wassil · Executive Vice President, Chief Operating Officer and Chief Scientific Officer
    Source: company website

More biotech & pharma companies

  • Watchmaker Genomics

    Enzymes and reagents for NGS library prep and molecular diagnostics, sold to life science researchers and diagnostics developers
    United StatesBiotech & pharma1 open job
    Remote-friendly

  • Acadia Pharmaceuticals

    Develops medicines for people with neurological and rare diseases
    San Diego, United StatesBiotech & pharmaFounded 19938 open jobs
    Remote-friendly

  • Allucent

    Contract research services for small and mid-size biotech and biopharma sponsors in clinical development and regulatory strategy
    Cary, United StatesBiotech & pharma15 open jobs
    Remote-friendly

  • Altos Labs

    Biotech developing cell rejuvenation medicines to reverse disease, with sites in San Francisco Bay Area, San Diego and Cambridge, UK
    United StatesBiotech & pharma3 open jobs
    Salary transparent

  • Ascendis Pharma

    Biopharmaceutical company developing rare endocrine and oncology therapies on its TransCon platform for patients and physicians
    United StatesBiotech & pharma41 open jobs

  • Beeline Medicines

    Clinical-stage biotech developing precision therapies for autoimmune and inflammatory diseases, led by a lupus candidate
    United StatesBiotech & pharma1 open job
    New on EvolcRemote-friendlySalary transparent

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Cloudflare
  • CookieYes
  • Google Tag Manager
  • Google Universal Analytics
  • Greenhouse
  • WordPress
  • jQuery